These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 36149256)

  • 41. At age 9, the methylome of assisted reproductive technology children that underwent embryo culture in different media is not significantly different on a genome-wide scale.
    Koeck RM; Busato F; Tost J; Zandstra H; Remy S; Langie S; Gielen M; van Golde R; Dumoulin JCM; Brunner H; Zamani Esteki M; van Montfoort APA
    Hum Reprod; 2022 Oct; 37(11):2709-2721. PubMed ID: 36206092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Performance comparison of two whole genome amplification techniques in frame of multifactor preimplantation genetic testing.
    Volozonoka L; Perminov D; Korņejeva L; Alkšere B; Novikova N; Pīmane EJ; Blumberga A; Kempa I; Miskova A; Gailīte L; Fodina V
    J Assist Reprod Genet; 2018 Aug; 35(8):1457-1472. PubMed ID: 29687370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ready for polygenic risk scores? An analysis of regulation of preimplantation genetic testing in European countries.
    Siermann M; van der Schoot V; Bunnik EM; Borry P
    Hum Reprod; 2024 May; 39(5):1117-1130. PubMed ID: 38514452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.
    Cimadomo D; Capalbo A; Dovere L; Tacconi L; Soscia D; Giancani A; Scepi E; Maggiulli R; Vaiarelli A; Rienzi L; Ubaldi FM
    Hum Reprod; 2021 Mar; 36(4):929-940. PubMed ID: 33608730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What is the reproductive potential of day 7 euploid embryos?
    Hernandez-Nieto C; Lee JA; Slifkin R; Sandler B; Copperman AB; Flisser E
    Hum Reprod; 2019 Sep; 34(9):1697-1706. PubMed ID: 31398251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracytoplasmic sperm injection is not superior to conventional IVF in couples with non-male factor infertility and preimplantation genetic testing for aneuploidies (PGT-A).
    De Munck N; El Khatib I; Abdala A; El-Damen A; Bayram A; Arnanz A; Melado L; Lawrenz B; Fatemi HM
    Hum Reprod; 2020 Feb; 35(2):317-327. PubMed ID: 32086522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical application of next generation sequencing-based haplotype linkage analysis in the preimplantation genetic testing for germline mosaicisms.
    Chen D; Xu Y; Fu Y; Wang Y; Liu Y; Ding C; Cai B; Pan J; Wang J; Li R; Guo J; Zhang H; Zeng Y; Shen X; Zhou C
    Orphanet J Rare Dis; 2023 Jun; 18(1):137. PubMed ID: 37270548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parameters of poor prognosis in preimplantation genetic testing for monogenic disorders.
    Van Der Kelen A; Santos-Ribeiro S; De Vos A; Verdyck P; De Rycke M; Berckmoes V; Tournaye H; Blockeel C; De Vos M; Hes FJ; Keymolen K; Verpoest W
    Hum Reprod; 2021 Aug; 36(9):2558-2566. PubMed ID: 34142115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
    Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
    Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inconclusive chromosomal assessment after blastocyst biopsy: prevalence, causative factors and outcomes after re-biopsy and re-vitrification. A multicenter experience.
    Cimadomo D; Rienzi L; Romanelli V; Alviggi E; Levi-Setti PE; Albani E; Dusi L; Papini L; Livi C; Benini F; Smeraldi A; Patassini C; Ubaldi FM; Capalbo A
    Hum Reprod; 2018 Oct; 33(10):1839-1846. PubMed ID: 30239718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic diseases and aneuploidies can be detected with a single blastocyst biopsy: a successful clinical approach.
    Minasi MG; Fiorentino F; Ruberti A; Biricik A; Cursio E; Cotroneo E; Varricchio MT; Surdo M; Spinella F; Greco E
    Hum Reprod; 2017 Aug; 32(8):1770-1777. PubMed ID: 28633287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive chromosome screening and gene expression analysis from the same biopsy in human preimplantation embryos.
    Marin D; Wang Y; Tao X; Scott RT; Treff NR
    Mol Hum Reprod; 2017 May; 23(5):330-338. PubMed ID: 28369516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-invasive preimplantation genetic testing (niPGT): the next revolution in reproductive genetics?
    Leaver M; Wells D
    Hum Reprod Update; 2020 Jan; 26(1):16-42. PubMed ID: 31774124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A rationale for biopsying embryos reaching the morula stage on Day 6 in women undergoing preimplantation genetic testing for aneuploidy.
    Irani M; Zaninovic N; Canon C; O'Neill C; Gunnala V; Zhan Q; Palermo G; Reichman D; Rosenwaks Z
    Hum Reprod; 2018 May; 33(5):935-941. PubMed ID: 29546326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.
    Capalbo A; Fabiani M; Caroselli S; Poli M; Girardi L; Patassini C; Favero F; Cimadomo D; Vaiarelli A; Simon C; Rienzi LF; Ubaldi FM
    Hum Reprod; 2021 Jun; 36(7):2050-2061. PubMed ID: 34021342
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Looking past the appearance: a comprehensive description of the clinical contribution of poor-quality blastocysts to increase live birth rates during cycles with aneuploidy testing.
    Cimadomo D; Soscia D; Vaiarelli A; Maggiulli R; Capalbo A; Ubaldi FM; Rienzi L
    Hum Reprod; 2019 Jul; 34(7):1206-1214. PubMed ID: 31247100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
    Lipton JH; Zargar M; Warner E; Greenblatt EE; Lee E; Chan KKW; Wong WWL
    Hum Reprod; 2020 Feb; 35(2):434-445. PubMed ID: 32099994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Next-generation sequence-based preimplantation genetic testing for monogenic disease resulting from maternal mosaicism.
    Hu X; He WB; Zhang SP; Luo KL; Gong F; Dai J; Zhang Y; Wan ZX; Li W; Yuan SM; Tan YQ; Lu GX; Lin G; Du J
    Mol Genet Genomic Med; 2021 May; 9(5):e1662. PubMed ID: 33942572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complex preimplantation genetic tests for Robertsonian translocation, HLA, and X-linked hyper IgM syndrome caused by a novel mutation of CD40LG gene.
    Huang S; Niu Y; Li J; Gao M; Zhang Y; Yan J; Ma S; Gao X; Gao Y
    J Assist Reprod Genet; 2020 Aug; 37(8):2025-2031. PubMed ID: 32500460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ESHRE survey results and good practice recommendations on managing chromosomal mosaicism.
    ; De Rycke M; Capalbo A; Coonen E; Coticchio G; Fiorentino F; Goossens V; Mcheik S; Rubio C; Sermon K; Sfontouris I; Spits C; Vermeesch JR; Vermeulen N; Wells D; Zambelli F; Kakourou G
    Hum Reprod Open; 2022; 2022(4):hoac044. PubMed ID: 36349144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.